Stock 8699 HS HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News HS Holdings Co., Ltd.

Equities

8699

JP3160790006

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-12 am EDT 		5-day change 1st Jan Change
962 JPY +0.42% Intraday chart for HS Holdings Co., Ltd. -2.14% -4.66%
Jul. 09 Avalo Therapeutics Announces Active IND for AVTX-009, an Anti-IL-1ß mAb, to Treat Hidradenitis Suppurativa CI
Jul. 08 Kymera Therapeutics, Inc. Announces Expansion of KT-474 HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Avalo Therapeutics Announces Active IND for AVTX-009, an Anti-IL-1ß mAb, to Treat Hidradenitis Suppurativa
CI
Kymera Therapeutics, Inc. Announces Expansion of KT-474 HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy
CI
HS Optimus Units Enters Share Subscription Agreement with One Equity
MT
HS Optimus’ Attributable Loss Trims in Fiscal H2
MT
GSK: to present its advances in oncology at ASCO
CF
HS Optimus Guides for Narrower Net Loss in Fiscal 2024
MT
New Russian owner of Hyundai's old St Petersburg plant launches Solaris production
RE
HS Optimus Unit to Re-enter Singapore Door Market But Faces Price Pressures from Overseas Rivals
MT
Iceland volcano leaves trail of damage
RE
Iceland volcano fades but leaves residents in the cold
RE
Hansoh Pharmaceutical Gets Nod to Trial Nephropathy Treatment Capsules
MT
Iceland builds defences for a future of increased volcanic activity
RE
Holcim takes 'rock star' North American business to Wall Street
RE
Indian devotees splurge on jets, gold idols as Hindu temple opens
RE
U.S. sanctions UAE shipping firm for violating Russian crude oil price cap
RE
Hansoh Pharmaceutical Units Gets Clinical Trial Notice in China for Schizophrenia Treatment
MT
Hap Seng Lending Arm's Loans Granted Reach MYR2.4 Billion As of End-2023
MT
AbbVie Says Phase 2 Trial of Lutikizumab Shows Higher Response Rates
MT
GSK Enters Exclusive License Agreement With Hansoh for HS-20093 Cancer Antibody
DJ
GSK: licensing agreement with Chinese company Hansoh
CF
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8699 Stock
  4. News HS Holdings Co., Ltd.